Identification:
1647501398663590400
fall, 2022-03-17 07:05
Britain’s drugs regulator said on Thursday it has approved AstraZeneca’s antibody-based treatment to prevent COVID-19 in people with a poor immune response.
Main Category:
Vietnam ends COVID-19 quarantine for international travelers